A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

Dystonia is a movement disorder of uncertain pathogenesis that is characterized by involuntary and inappropriate muscle contractions which cause sustained abnormal postures and movements of multiple or single (focal) body regions. The most common focal dystonias are cervical dystonia (CD) and blepha...

Descripción completa

Detalles Bibliográficos
Autor principal: Jimenez-Shahed, Joohi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261649/
https://www.ncbi.nlm.nih.gov/pubmed/22275842
http://dx.doi.org/10.2147/NDT.S16085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261649/
https://www.ncbi.nlm.nih.gov/pubmed/22275842
http://dx.doi.org/10.2147/NDT.S16085

Ejemplares similares